BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Liang TT. CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells. AMB Express 2020;10:54. [PMID: 32185543 DOI: 10.1186/s13568-020-00990-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Kousar K, Naseer F, Abduh MS, Kakar S, Gul R, Anjum S, Ahmad T. Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma. Front Pharmacol 2023;13. [DOI: 10.3389/fphar.2022.1073004] [Reference Citation Analysis]
2 Lamberti MJ, Montico B, Ravo M, Nigro A, Giurato G, Iorio R, Tarallo R, Weisz A, Stellato C, Steffan A, Dolcetti R, Casolaro V, Faè DA, Dal Col J. Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death. Biomedicines 2022;10:1896. [DOI: 10.3390/biomedicines10081896] [Reference Citation Analysis]
3 Toma I, Porfire AS, Tefas LR, Berindan-Neagoe I, Tomuță I. A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA. Pharmaceutics 2022;14:1482. [PMID: 35890377 DOI: 10.3390/pharmaceutics14071482] [Reference Citation Analysis]
4 Parashar D, Singh A, Gupta S, Sharma A, Sharma MK, Roy KK, Chauhan SC, Kashyap VK. Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer. Genes (Basel) 2022;13:1254. [PMID: 35886037 DOI: 10.3390/genes13071254] [Reference Citation Analysis]
5 Bhattacharjee R, Dey T, Kumar L, Kar S, Sarkar R, Ghorai M, Malik S, Jha NK, Vellingiri B, Kesari KK, Pérez de la Lastra JM, Dey A. Cellular landscaping of cisplatin resistance in cervical cancer. Biomed Pharmacother 2022;153:113345. [PMID: 35810692 DOI: 10.1016/j.biopha.2022.113345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gao X, Wang W, Gao M. Preparation of Novel ICT-CMC-CD59sp Drug-Loaded Microspheres and Targeting Anti-Tumor Effect on Oral Squamous Cell Carcinoma. Front Bioeng Biotechnol 2022;10:878456. [PMID: 35387305 DOI: 10.3389/fbioe.2022.878456] [Reference Citation Analysis]
7 van der Koog L, Gandek TB, Nagelkerke A. Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization. Adv Healthc Mater 2022;11:e2100639. [PMID: 34165909 DOI: 10.1002/adhm.202100639] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 28.0] [Reference Citation Analysis]
8 Ghosh D, Ramoutar R, Landge S. Dynamic effects of organic molecules for drug delivery in micelles. Contemporary Chemical Approaches for Green and Sustainable Drugs 2022. [DOI: 10.1016/b978-0-12-822248-5.00013-9] [Reference Citation Analysis]
9 Bozzer S, Bo MD, Toffoli G, Macor P, Capolla S. Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model. Pharmaceutics 2021;13:1106. [PMID: 34452067 DOI: 10.3390/pharmaceutics13081106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Lamberti MJ, Nigro A, Casolaro V, Rumie Vittar NB, Dal Col J. Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome. Cancers (Basel) 2021;13:2566. [PMID: 34073766 DOI: 10.3390/cancers13112566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhou P, Liu W, Cheng Y, Qian D. Nanoparticle-based applications for cervical cancer treatment in drug delivery, gene editing, and therapeutic cancer vaccines. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1718. [PMID: 33942532 DOI: 10.1002/wnan.1718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu Z, Chu W, Sun Q, Zhao L, Tan X, Zhang Y, Yin T, He H, Gou J *, Tang X. Micelle-contained and PEGylated hybrid liposomes of combined gemcitabine and cisplatin delivery for enhancing antitumor activity. Int J Pharm 2021;602:120619. [PMID: 33887396 DOI: 10.1016/j.ijpharm.2021.120619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
13 Masadah R, Rauf S, Pratama MY, Tiribelli C, Pascut D. The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer. Cancers (Basel) 2021;13:1168. [PMID: 33803151 DOI: 10.3390/cancers13051168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Raue R, Frank AC, Syed SN, Brüne B. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. Int J Mol Sci 2021;22:2210. [PMID: 33672261 DOI: 10.3390/ijms22042210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
15 Wen X, Liu S, Sheng J, Cui M. Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer. PeerJ 2020;8:e9234. [PMID: 32523813 DOI: 10.7717/peerj.9234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]